
Singapore-Developed Cancer Immunotherapy Brings New Hope to Late-Stage Patients
In a groundbreaking development that could reshape the landscape of cancer immunotherapy, researchers from Singapore’s ASTAR Institute of Molecular and Cell Biology (IMCB) in collaboration with biotechnology company Intra-ImmuSG have unveiled promising …